Arkadios Wealth Advisors »

Fs Global Cr Opportunitie Fda shares owned by Arkadios Wealth Advisors

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Arkadios Wealth Advisors from 13F filings

Historical chart of Arkadios Wealth Advisors investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Arkadios Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Arkadios Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $349k 59k 5.93
2023-12-31 $269k 48k 5.67
2023-09-30 $436k 81k 5.42
2023-06-30 $451k 95k 4.75
2023-03-31 $277k 62k 4.44

More positions owned by Arkadios Wealth Advisors

Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Angel Oak Income Etf Etf (CARY)
Amazon Stock (AMZN)
Invesco Russell 1000 Dynamic Multifactor Etf Etf (OMFL)
Microsoft Corp Stock (MSFT)
Ishares Msci Usa Equal Weighted Etf Etf (EUSA)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard S&p 500 Etf Etf (VOO)
Ft Cboe Vest Fund Of Buffer Etfs Etf (BUFR)
Invesco Qqq Trust Series I Etf (QQQ)
Copper Place Global Dividend Growth Etf Etf (GDVD)
Invesco S&p 500 Pure Growth Etf Etf (RPG)
Ft Vest S&p 500 Dividend Aristocrats Target Income Etf Etf (KNG)
Johnson & Johnson Stock (JNJ)

View all positions for Arkadios Wealth Advisors

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Saba Capital Management
Wagner Wealth Management
Penserra Capital Management
Advisor Group Holdings
H D Vest Advisory Services
Rockefeller Capital Management
Royal Bank of Canada
Kestra Advisory Services
Ellis Investment Partners
Prime Capital Investment Advisors
Feltz Wealth PLAN

View all funds holding Fs Global Cr Opportunitie Fda